Wound biofilm — structured communities of bacteria embedded in a self-produced polysaccharide matrix — has transformed our understanding of why diabetic foot ulcers plateau and fail to heal despite apparently appropriate wound care. Biofilm is present in an estimated 60–80% of chronic wounds, is invisible to the naked eye, is profoundly resistant to systemic and topical antibiotics, and is the primary reason chronic wounds fail to progress through normal healing phases. Recognition and systematic biofilm management is now a central component of diabetic foot ulcer care.

What Makes Biofilm Different from Planktonic Bacteria

Planktonic (free-floating) bacteria are the form for which standard antibiotic susceptibility testing is performed, and which most wound care protocols were historically designed to address. Biofilm bacteria are fundamentally different: encased within a glycocalyx matrix that physically excludes many antibiotics, they exhibit dramatically reduced metabolic activity (making them less susceptible to antibiotics that target active metabolism), express altered gene expression profiles that upregulate resistance mechanisms, and communicate through quorum-sensing signals that coordinate community-wide virulence behaviors. The minimum inhibitory concentration (MIC) for antibiotics against biofilm bacteria is 100–1000× higher than for the same organisms in planktonic form — meaning that standard antibiotic dosing that would adequately treat a planktonic infection is essentially ineffective against established biofilm. Biofilm bacteria also evade the host immune response — neutrophils and macrophages can engulf planktonic bacteria but are unable to effectively penetrate the biofilm matrix.

Biofilm Recognition in the Clinic

Biofilm cannot be identified by wound appearance with certainty, but characteristic signs suggest its presence: a wound that has plateau in healing despite appropriate standard care for ≥4 weeks, a wound surface with a shiny or “glassy” appearance, easy re-formation of fibrinous slough within 2–3 days after sharp debridement, wound friability and poor granulation tissue formation, and elevated inflammatory markers (elevated local wound temperature, persistent periwound erythema) without systemic infection signs. Biofilm is confirmed by quantitative wound tissue culture demonstrating high bacterial density (>10^5 organisms/gram of tissue) or by confocal microscopy of wound specimens — tools used in research settings but rarely in clinical practice.

Biofilm Management: Debridement Plus Targeted Topicals

The cornerstone of biofilm management is repeated aggressive sharp debridement — physically disrupting the biofilm matrix and converting the chronic wound to an acute wound environment. Cadexomer iodine (Iodosorb gel or dressings) has the strongest evidence base among topical antimicrobials for biofilm disruption: the cadexomer starch matrix releases iodine slowly, maintaining sustained biofilm-disrupting concentrations, and the physical absorption of the cadexomer granules exerts mechanical debridement on the biofilm. Polyhexamethylene biguanide (PHMB)-containing dressings and silver-releasing dressings also demonstrate biofilm-disrupting activity. The frequency of debridement and dressing change must be increased to prevent re-establishment of biofilm — weekly debridement intervals, standard for many wound care protocols, may allow biofilm to re-mature between visits. Dr. Biernacki at Balance Foot & Ankle provides biofilm-aware wound care with serial sharp debridement and evidence-based antimicrobial dressing protocols for diabetic foot ulcers. Call (810) 206-1402.

Why Regular Podiatric Care Is Essential for Diabetics

Diabetes affects the feet in two critical ways that work together to create risk: neuropathy (loss of protective sensation) and peripheral arterial disease (reduced circulation). Together, these mean that small injuries can go unnoticed and heal poorly — creating a pathway to serious infection.

The Numbers That Matter for Your Feet

• HbA1c below 7%: The ADA goal for most diabetics — higher levels accelerate neuropathy and circulation damage
• Annual comprehensive foot exam: Standard of care for all diabetics
• Daily foot inspections: Check for cuts, blisters, redness, swelling, or changes in skin color
• Never barefoot: Loss of sensation means you may step on something without feeling it

At Balance Foot & Ankle, we see diabetic patients for comprehensive foot care including neuropathy screening, nail care, wound assessment, and diabetic orthotics.